RE: Exceeding expectations3 Dec 2020 09:42
Cenkos note.. sorry I can’t publish link as has my account.
DIRECTA PLUS
Trading ahead of expectations
“Directa Plus has released a trading update guiding to revenue for FY20 of approximately €6.0m, 9% ahead of our expectations of €5.5m. The strong trading performance has been primarily driven by the sales of G+ enhanced face masks, including Co-Masks, which have proven popular with both individual and corporate customers and have generated strong demand. The strengthening performance of Setcar, the Environmental division, has also contributed to the improved revenue expectations for the current year.
The company has also announced a new development agreement with the Soft Goods Division of a major international developer and manufacturer of consumer electronics, personal computers and related services. The agreement covers the potential application of G+® graphene on covering materials of consumer devices, exploiting the antiviral- antibacterial properties of G+® graphene as well as its thermal and electrical conductivity. Directa Plus has been granted a new and second patent on its core plasma technology; specifically relating to new machinery with five times the previous capacity and greater durability.
? Comment: We believe today’s announcement is positive, especially considering Italy and most of Europe entered some form of pandemic related lockdown only around a month after the publication of our expectations in September. With several key business lines likely to have been impacted by this, such as textiles and performance workwear in particular (usually bought in public tenders), it is clear that the company’s rapid move into G+ enhanced facemasks was a good one and has more than made up the difference.
We see the signing of a new development agreement as another positive step forward, and whilst only a development agreement with the Soft Goods Division, there are very few small international developer and manufacturer of consumer electronics, personal computers and related services. The partner is likely quite sizeable and we can see particular interest for graphene to enhance consumer electronics, particularly anti-bacterial and anti-viral properties for cases, keyboards and other peripherals. We iterate our view that Directa Plus as an underappreciated, undervalued and more mature and lower risk play in the UK and international listed graphene and speciality nanomaterials space and maintain our Buy recommendation and 122p price target.”
Trek